Clinical Research Directory
Browse clinical research sites, groups, and studies.
BOOM-IBD2 Pivotal Clinical Trial
Sponsor: Boomerang Medical
Summary
The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.
Official title: BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
137
Start Date
2025-01-31
Completion Date
2026-10
Last Updated
2025-07-03
Healthy Volunteers
No
Interventions
Neuromodulation
Neuromodulation
Locations (10)
Center for Colorectal Innovation
Los Angeles, California, United States
Hoag Hospital
Newport Beach, California, United States
PAMF (Palo Alto Medical Foundation)
Palo Alto, California, United States
Kansas Gastro
Wichita, Kansas, United States
Objective Health - St. Louis
St Louis, Missouri, United States
Las Vegas Medical Research LLC, DBA Vector Clinical Trials
Las Vegas, Nevada, United States
Columbia University Irving Medical Center/New York Presbyterian Hospital
New York, New York, United States
UNC Chapel Hill
Chapel Hill, North Carolina, United States
Objective Health - Amarillo
Amarillo, Texas, United States
Objective Health - Central Texas
Waco, Texas, United States